|

Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)

RECRUITINGN/ASponsored by Centre Paul Strauss
Actively Recruiting
PhaseN/A
SponsorCentre Paul Strauss
Started2021-09-17
Est. completion2030-10-17
Eligibility
Age75 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05066139

Summary

This is a monocentric, comparative, open-label, randomized parallel group study enrolling elderly subjects hospitalized in Strasbourg Europe Cancerology Institute (ICANS), starting chemotherapy or targeted therapy for the treatment of digestive cancer.

Eligibility

Age: 75 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients must be ≥ 75 years old
* Performance status 0, 1 or 2
* Diagnostic of digestive cancer, all stages (adjuvant or metastatic), with an indication for chemotherapy treatment or targeted therapy for a treatment period of 24 weeks or more
* Patients previously treated with one or several lines of chemotherapy for this digestive cancer are eligible
* Estimated life expectancy ≥ 3 months
* Patients able to speak, read and understand French
* Signed informed consent from the patient
* Patients must have a social security coverage

Exclusion Criteria:

* History of differentiated neuroendocrine tumors grade 1 or 2 (pancreas, small intestine)
* Cancer currently being treated (except for hormone therapy) other than current digestive cancer
* History of major surgery and/or curative radiation therapy during the last 4 weeks before inclusion
* Patients unable to submit to medical follow-up for geographical, social or psychological reasons
* Patients placed under guardianship

Conditions3

CancerDigestive System DiseaseNeoplasms

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.